格菲妥单抗
Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg
Product Availability
3-5days
Price
$1100.00
Member price
Product Availability
3-5days
Price
$1600.00
Member price
Quantity
- +
Product Overview
Product Name Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)
CAS2229047-91-8
AppearanceColorless to light yellow liquid
Storage conditionstore at -20°C
Security information
Product details

 Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab is used as an effective therapy for relapsed or refractory diffuse large B-cell lymphoma.


Related
Sorry, no related items
History
Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)
Siplizumab (Synonyms: MEDI-507)
Ranibizumab (Anti-VEGFA)
Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7)
Abatacept (Synonyms: CTLA4lg; BMS-188667)
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
Gatipotuzumab | PankoMab
Bimagrumab (Synonyms: Anti-ACVR2B Reference Antibody; BYM338)